For pharmaceutical, human and agricultural biotechnology, and medical products, technology and devices companies, the life sciences industry is changing at an unprecedented rate. Growing customer needs, revolution in R&D and drug discovery, shifting markets and sources, evolution of the biotech sector, emergence of the specialty and generic sectors, worldwide efforts to control healthcare costs and an evolving regulatory and compliance environment create both opportunities and challenges for life sciences companies.